Eli Lilly

weight loss scale weigh measure tape obesity overweight
Biotech

Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients

With another orforglipron trial already in the books, Lilly has unveiled the rest of the data underpinning the med's obesity approval bid.
Fraiser Kansteiner Aug 26, 2025 6:45am
parachute south africa cape town

Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders

Aug 22, 2025 8:30am
Dollar sign on digital background

Lilly pens $1.3B pact with Superluminal to work on GPCR drugs

Aug 14, 2025 9:45am
reshuffle pipeline target reorganize shift change

Lilly shakes up pain pipeline as part of quarterly R&D clearout

Aug 7, 2025 8:28am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am
Open farm gate leading into agricultural landscape

Lilly links up with Gate in $856M biobucks deal

Jul 24, 2025 2:32pm